2seventy bio Inc
NASDAQ:TSVT 2:12:25 PM EDT
Earnings Announcements
2Seventy Bio Announces $94 Million In U.S. Revenue For Abecma In Q4
Published: 02/02/2023 14:43 GMT
2seventy bio Inc (TSVT) - 2seventy Bio - on Feb 2, Co Announced Abecma Generated About $94 Million in U.S. Revenue During Q4 & About $297 Million in U.S. Revenue During Year Ended Dec 31, 2022.
Revenue is expected to be $23.16 Million
Adjusted EPS is expected to be -$1.25
Next Quarter Revenue Guidance is expected to be $27.91 Million
Next Quarter EPS Guidance is expected to be -$1.12
More details on our Analysts Page.
Adjusted EPS is expected to be -$1.25
Next Quarter Revenue Guidance is expected to be $27.91 Million
Next Quarter EPS Guidance is expected to be -$1.12
More details on our Analysts Page.